Efficacy analysis.

Baseline characteristics of study cohort.

Correlation of pre- and post-serum values at both timepoints. Correlation of pre- (black circle) and post- (white circle) NAT serum values at timepoint 0 and after 1 year (+1a)....

Aims: The study evaluated real-world cost of treatment in multiple sclerosis (MS) patients initiating infused disease-modifying-therapies (DMT) in United States. Materials and...

In order to help patients to understand the meaning of the therapeutic scenario-associated risks, we also presented five scenarios totally unrelated to MS or MS treatments with...

Natalizumab is an effective therapy for multiple sclerosis (MS). Its effectiveness has been demonstrated in several clinical and imaging studies. The objective of this study was...

Subgroup comparison data.

Longitudinal clinical and imaging metrics over 96-week treatment period.

Demographic and disease characteristics of the study population.